Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD25- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NKT Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / Neutrophils
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Monocyte differential count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.931
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Large Unstained Cell (LUC) differential count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.562
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
5.77×10-06
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / Eosinophils
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Lymphocyte cell count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.871
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
1.54×10-21
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / B1B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Mean platelet volume
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.138
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Eosinophil differential count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.510
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / cDCs
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NKT Subsets (Q3)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Neutrophil differential count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.523
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD25- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NK Subsets (Q1)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Monocyte cell count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.982
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Mean cell volume
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
1.28×10-17
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD25- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Hematocrit
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.668
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NK Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / White blood cell count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.954
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Eosinophil cell count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.563
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Red blood cell distribution width
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000585
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Basophil cell count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0577
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / B1B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Red blood cell count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
5.63×10-10
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / T cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Hematocrit
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.504
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NK Subsets (Q3)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NK Subsets (Q2)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Mean platelet volume
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000384
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Basophil differential count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.567
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD25- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NKT Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Neutrophil cell count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.926
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / Neutrophils
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / T Subset
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Large Unstained Cell (LUC) count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0119
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NK Subsets (Q4)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Lymphocyte cell count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.550
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Platelet count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0199
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Platelet count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00362
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / Monocytes
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
6.17×10-06
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Mean cell volume
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
4.16×10-20
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Lymphocyte differential count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.916
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NKT Subsets (Q1)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Monocyte cell count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.630
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD25- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NK Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Hemoglobin
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
6.44×10-05
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
2.26×10-31
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD25- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / B2B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Monocyte differential count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.685
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / Eosinophils
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Large Unstained Cell (LUC) differential count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0261
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / MZB (CD21/35 high)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Eosinophil cell count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.724
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / cDCs
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Hemoglobin
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
2.67×10-05
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Basophil differential count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.231
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NK Subsets (Q2)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / MZB (CD21/35 high)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Eosinophil differential count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0635
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NK Subsets (Q1)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Basophil cell count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.135
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / B2B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NKT Subsets (Q3)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NK Subsets (Q4)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Red blood cell count
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
1.34×10-07
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / Monocytes
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Neutrophil differential count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.965
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Red blood cell distribution width
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.902
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Large Unstained Cell (LUC) count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.535
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Organ Weight / Spleen weight
|
HOM
|
4f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.00152
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NK Subsets (Q3)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / NKT Subsets (Q1)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Clinical Chemistry / Glycosilated hemoglobin A1c (HbA1c)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.202
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / T cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Lymphocyte differential count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.875
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / T Subset
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / Neutrophil cell count
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.534
|
Successful |
Tfr2em1(IMPC)Rbrc
|
RBRC
|
Hematology / White blood cell count
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.726
|
Successful |